Fri, Dec 26, 2014, 1:08 PM EST - U.S. Markets close in 2 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

Zalicus Inc. Message Board

  • bmwcyclehwy1 bmwcyclehwy1 Sep 20, 2013 10:51 AM Flag

    ZLCS Revenues are REAL

    This is what people need to realize, and that is Zalicus is generating revenue. I find this to be one of the most important dynamics going forward. Below is a piece of this mornings new article.

    "Not many biotechs trading under $3 generate any revenues. If Z160 is successful in clinical trials and matches gabapentin, or lyrica sales, it would easily justify a stock price over 20 times the current price. Analysts have estimated the market opportunity for Z160 to be anywhere from $500 million to $2.7 billion. Comparable to peak sales for gabapentin. Z160 could see significant off label usage being that it is a non-opioid with a superior side effect profile. The FDA has made a significant effort to approve drugs with less abuse potential which favors non-opioids such as Z160."

    Sentiment: Strong Buy

 
ZLCS
1.18+0.03(+2.61%)Jul 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.